Found 5 matching trials
Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia) PHASE3 This study will test the ability of the topical cream WR 279,396 to treat t...
Show More Location
Central Clinic-Sidi Bouzid
Learn More & Join Trial
Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama PHASE2 The objectives of the study are to evaluate the pharmacokinetics (PK), safe...
Show More Location
Gorgas Memorial Institute Clinical Research Unit
Learn More & Join Trial
Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK) PHASE2 The objectives of the study are to evaluate the pharmacokinetics (PK), safe...
Show More Location
Universidad Peruana Cayetano Heredia (UPCH)
Learn More & Join Trial
Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis PHASE2 Cure rate for L braziliensis bolivian CL has been 70%-80% for standard syst...
Show More Location
Hopital, Dermatologico
Learn More & Join Trial
Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama PHASE3 This study is a pivotal Phase 3, randomized, double-blind, 3-site, two-grou...
Show More Location
Instituto Conmemorativo Gorgas de Estudios de la Salud,
Learn More & Join Trial